Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc.

EIGR

शेयरों में रैंक #36423
Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company... Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and bringing to market targeted therapies for rare and ultra-rare diseases across the United States and internationally. Its primary investigational drug, Lonafarnib, an orally administered small molecule, is currently undergoing Phase III clinical trials for the treatment of hepatitis delta virus (HDV) infection. Other promising candidates in its portfolio include Lambda, which has completed Phase II clinical trials and is designed to target type III interferon receptors; Lonafarnib, also being evaluated for progeria and progeroid laminopathies; and Avexitide, an agent for congenital hyperinsulinism that has also successfully concluded Phase II studies for post-bariatric hypoglycemia. Established in 2008, Eiger BioPharmaceuticals, Inc. maintains its headquarters in Palo Alto, California.
शेयर मूल्य
$1.73
अंतिम समन्वयन: 2025-06-17
मार्केट कैप
$2.55M
बदलाव (1 दिन)
-0.29%
बदलाव (1 वर्ष)
-79.71%
देश
US
व्यापार Eiger BioPharmaceuticals, Inc. (EIGR)

श्रेणी

Healthcare
Eiger BioPharmaceuticals, Inc. (EIGR) के लिए स्टॉक विभाजन इतिहास
Eiger BioPharmaceuticals, Inc. स्टॉक (प्रतीक: EIGR) में कुल 2 स्टॉक विभाजन हुए।
सबसे हाल का स्टॉक विभाजन Jan 08, 2024 को हुआ।
Mar 23, 2016 से पहले खरीदा गया एक EIGR शेयर अब 0.0022222222222222 EIGR शेयरों के बराबर होगा।
स्टॉक विभाजन सूची
वर्ष विभाजन गुणक संचयी गुणक
2024-01-08 1:30 x0.033333333333333 x0.0022222222222222
2016-03-23 1:15 x0.066666666666667 x0.066666666666667
समान कंपनियों या प्रतिस्पर्धियों के लिए स्टॉक विभाजन
कंपनी स्टॉक विभाजनों की संख्या संचयी गुणक देश
1 x2
US
0 -
US
1 x3
AU
0 -
NL
0 -
CH